Jeevan Scientific Technology

42.00
+0.43
(1.03%)
Market Cap
66.48 Cr
EPS
-0.86
PE Ratio
94.48
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
67.80
52 Week Low
37.99
PB Ratio
1.30
Debt to Equity
0.24
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
727.00
#1 29,264.44
61.48
#1 3,579.20
9.66
#1 510
17.58
55.64
570.15
13,681.01
36.09
2,665.90
12.77
337
11.03
53.38
126.32
2,754.71
-
32.80
#1 49.09
-105
6.46
54.30
972.20
2,160.50
35.92
322.30
0.22
41
112.87
49.57
87.31
205.54
-
769.70
-22.39
-59
17.26
57.73
8.67
128.26
-
67.20
-65.97
-120
#1 2,371.43
52.07
42.00
#7 66.48
#5 94.48
#7 40.30
#5 8.04
#5 -1
#2 120.00
49.00
16.00
26.30
#1 33.09
80.00
-3.26
2
-80.00
37.86
24.20
15.30
-
9.80
40.00
-9
-380.00
42.85
Growth Rate
Revenue Growth
8.04 %
Net Income Growth
-58.06 %
Cash Flow Change
145.09 %
ROE
-56.87 %
ROCE
-78.00 %
EBITDA Margin (Avg.)
104.20 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
3
0
9
5
4
5
4
5
6
5
5
6
5
6
8
8
4
3
6
9
9
5
13
16
16
16
19
21
17
11
8
10
8
11
8
10
11
13
12
13
Expenses
3
0
7
4
4
4
3
4
4
5
4
5
4
5
6
6
5
5
6
6
14
5
7
8
11
10
12
14
14
9
8
9
9
8
8
9
10
10
9
10
EBITDA
1
0
2
1
-1
1
1
1
1
1
1
2
1
2
3
3
-1
-1
0
2
-5
1
6
9
5
6
7
7
3
2
-0
2
-1
2
1
1
1
3
3
2
Operating Profit %
20 %
0 %
16 %
19 %
-17 %
16 %
17 %
17 %
16 %
9 %
21 %
21 %
13 %
22 %
29 %
32 %
-15 %
-42 %
-6 %
23 %
-95 %
15 %
38 %
53 %
32 %
36 %
34 %
32 %
-18 %
12 %
-5 %
15 %
-13 %
20 %
7 %
10 %
9 %
25 %
22 %
17 %
Depreciation
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
2
2
2
2
Interest
0
0
1
0
0
0
0
0
0
0
1
1
0
0
1
1
0
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
1
0
-1
0
0
0
1
0
0
0
0
1
1
1
-2
-3
-2
1
-7
-1
4
7
4
5
5
6
2
0
-2
0
-3
1
-1
-1
-1
2
1
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
-0
-1
-0
0
-1
-0
1
1
0
1
2
2
2
-0
-0
0
-0
0
-0
-0
0
1
1
0
Net Profit
0
0
1
0
-1
0
0
0
1
0
0
0
-0
0
1
1
-2
-2
-1
0
-6
-1
3
6
4
3
4
4
1
0
-1
0
-2
1
-1
-1
-1
1
0
0
EPS in ₹
0.70
0.00
1.50
0.25
-1.77
0.16
0.20
0.24
0.51
0.03
0.09
0.12
-0.05
0.26
0.93
0.52
-0.97
-1.37
-0.95
0.26
-3.56
-0.37
1.79
3.74
2.56
2.17
2.45
2.80
0.52
0.25
-0.78
0.04
-1.51
0.33
-0.39
-0.31
-0.47
0.66
0.16
0.03

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
20
31
49
61
54
66
78
66
68
Fixed Assets
9
16
28
33
31
27
19
25
27
Current Assets
11
14
21
25
18
34
54
29
25
Capital Work in Progress
0
0
0
0
0
0
0
2
3
Investments
0
0
0
0
0
0
0
0
0
Other Assets
12
15
21
29
23
39
59
39
38
Total Liabilities
20
31
49
61
54
66
78
66
68
Current Liabilities
8
9
17
21
23
23
22
11
9
Non Current Liabilities
8
5
10
8
8
8
5
6
10
Total Equity
4
17
22
32
23
35
51
48
49
Reserve & Surplus
-2
3
7
17
8
20
35
33
33
Share Capital
6
9
12
15
15
15
15
16
16

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
1
2
-2
4
24
-23
-6
Investing Activities
-4
-9
-14
-8
-2
-1
-1
-7
-12
Operating Activities
4
-6
6
4
0
5
20
-6
3
Financing Activities
0
15
10
6
0
-0
6
-10
2

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
38.11 %
38.11 %
38.11 %
38.11 %
36.15 %
36.47 %
36.47 %
36.85 %
38.44 %
38.48 %
38.48 %
38.48 %
38.70 %
38.70 %
38.70 %
37.84 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
48.08 %
45.99 %
46.82 %
46.70 %
48.56 %
48.38 %
44.89 %
44.65 %
42.87 %
42.89 %
45.98 %
45.51 %
45.50 %
45.34 %
45.75 %
45.91 %
Others
13.81 %
15.90 %
15.06 %
15.18 %
15.29 %
15.15 %
18.64 %
18.50 %
18.69 %
18.63 %
15.53 %
16.00 %
15.80 %
15.96 %
15.55 %
16.25 %
No of Share Holders
2,740
3,999
5,499
5,813
6,144
6,439
6,449
6,295
6,061
5,911
5,933
5,727
5,749
5,655
5,607
5,565

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.5 1.2 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.38 2.38 0.00 0.00 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20183 days ago
Information About Successful Completion Of Inspection Of JSTL Clinical And Bioanalytical Facilities By CDSCO (Central Drugs Standard Control Organisation) Under Regulation 30 Of SEBI (LODR) Regulations 2015.9 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMMar 27, 2025
Closure of Trading WindowMar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 17, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 05, 2025
Notice Of Extra-Ordinary General Meeting To Be Held On 27Th March 2025 At 10:00 AM.Mar 03, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 01.03.2025Mar 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Copy Of News Paper Cuttings Of The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.Feb 08, 2025
Integrated Filing (Financial)Feb 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2025
Integrated Filing (Financial)Feb 06, 2025
Un Audited Results For The Quarter And Nine Months Ended 31.12.2024Feb 06, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2025Feb 06, 2025
Board Meeting Intimation for Intimation For The Board Meeting To Be Held On 06.02.2025.Jan 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 18, 2025
Closure of Trading WindowDec 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 12, 2024
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Nov 25, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementNov 08, 2024
Un Audited Financial Results ( Standalone And Consolidated) For The Quarter And Half Year Ended 30.09.2024Nov 08, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 08.11.2024Nov 08, 2024
Board Meeting Intimation for The Meeting To Be Held On 08.11.2024Nov 02, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 17, 2024
Closure of Trading WindowSep 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 10, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 09, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 09, 2024
Unaudited Financial Results For The Quarter Ended 30.06.2024Aug 09, 2024
Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended 30.06.2024 Under Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Aug 09, 2024
Board Meeting Intimation for The Meeting To Be Held On 09.08.2024Aug 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 19, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 19, 2024
Intimation Of Book Closure And Cut-Off Date For The 26Th Annual General Meeting Of Jeevan Scientific Technology LimitedJul 17, 2024
Reg. 34 (1) Annual Report.Jul 17, 2024
Shareholders Meeting-AGM- Friday, 09Th August 2024 At 10:00 AM.Jul 17, 2024
Closure of Trading WindowJun 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 20, 2024
Receipt Of Bioequivalence Center Approval From Sultanate Of Oman Ministry Of Health Drug Safety Center, OmanJun 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2024
Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31.03.2024May 30, 2024
Board Meeting Outcome for Outcome Of Board Meeting For The Quarter And Year Ended 31.03.2024 Under Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.May 30, 2024

Technical Indicators

RSI(14)
Neutral
49.00
ATR(14)
Less Volatile
2.09
STOCH(9,6)
Neutral
38.19
STOCH RSI(14)
Neutral
68.87
MACD(12,26)
Bullish
0.16
ADX(14)
Weak Trend
17.18
UO(9)
Bearish
32.30
ROC(12)
Uptrend And Accelerating
4.61
WillR(14)
Neutral
-44.85